Project Details
Description
Phase II Double blind, Multi -Centre Study of the Safety and Efficacy of MET-2 in Patients with Depression under CTA and IND
Status | Finished |
---|---|
Effective start/end date | 9/24/20 → 8/30/22 |
Funding
- NUBIYOTA LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.